Aehr Test Systems
AEHR
$36.46
$0.651.82%
Weiss Ratings | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | A | |||
Rating Factors | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Excellent | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 2.62 | |||
Price History | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.17% | |||
30-Day Total Return | 74.78% | |||
60-Day Total Return | 75.80% | |||
90-Day Total Return | 157.30% | |||
Year to Date Total Return | 98.26% | |||
1-Year Total Return | 199.10% | |||
2-Year Total Return | 1,329.80% | |||
3-Year Total Return | 1,713.93% | |||
5-Year Total Return | 1,478.35% | |||
52-Week High % Change | -3.99% | |||
52-Week Low % Change | 433.68% | |||
Price | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $37.30 | |||
52-Week Low Price | $6.71 | |||
52-Week Low Price (Date) | Jul 05, 2022 | |||
52-Week High Price (Date) | Feb 03, 2023 | |||
Valuation | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | $994.07M | |||
Enterprise Value | 958.10M | |||
Price/Earnings (TTM) | 82.25 | |||
Earnings Per Share (TTM) | 0.44 | |||
Earnings Per Share Growth | 878.43% | |||
Price/Earnings To Growth | 0.09 | |||
Price/Sales (TTM) | 17.06 | |||
Price/Book (Q) | 17.52 | |||
Enterprise Value/Revenue (TTM) | 15.69 | |||
Price | $36.46 | |||
Enterprise Value/EBITDA (TTM) | 77.47 | |||
Enterprise Value/EBIT | 79.72 | |||
Market Cap Category | Small Cap | |||
Dividends and Shares | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 29.080M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 510 623 9400 | |||
Address | 400 Kato Terrace Fremont, CA 94539 | |||
Website | www.aehr.com | |||
Country | United States | |||
Year Founded | 1977 | |||
Profitability | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 19.68% | |||
Profit Margin | 20.22% | |||
Management Effectiveness | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 11.95% | |||
Return on Equity | 25.33% | |||
Income Statement | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | $61.06M | |||
Total Revenue (TTM) | $61.06M | |||
Revenue Per Share | $2.10 | |||
Gross Profit (TTM) | $29.26M | |||
EBITDA (TTM) | $12.37M | |||
EBIT (TTM) | $12.02M | |||
Net Income (TTM) | $12.35M | |||
Net Income Avl. to Common (TTM) | $12.35M | |||
Total Revenue Growth (Q YOY) | 54.15% | |||
Earnings Growth (Q YOY) | 419.53% | |||
EPS Diluted (TTM) | $0.44 | |||
EPS Diluted Growth (Q YOY) | 374.45% | |||
Balance Sheet | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | $36.58M | |||
Cash Per Share (Q) | $1.26 | |||
Total Current Assets (Q) | $65.54M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | $56.67M | |||
Current Ratio (Q) | 6.099 | |||
Book Value Per Share (Q) | $2.04 | |||
Total Assets (Q) | $67.54M | |||
Total Current Liabilities (Q) | $10.75M | |||
Total Debt (Q) | $616.00K | |||
Total Liabilities (Q) | $10.88M | |||
Total Common Equity (Q) | $56.67M | |||
Cash Flow | AEHR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -$18.04M | |||
Cash from Financing (TTM) | $283.00K | |||
Net Change in Cash (TTM) | -$16.16M | |||
Levered Free Cash Flow (TTM) | -$2.81M | |||
Cash from Operations (TTM) | $1.56M | |||